Alterity Therapeutics Files 6-K, Cites Share Registry Change
Ticker: PRNAF · Form: 6-K · Filed: Oct 4, 2024 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Oct 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: administrative, registration-statement, share-registry
Related Tickers: ATHE
TL;DR
ALTERITY THERAPEUTICS LTD (ATHE) filed a 6-K for October 2024, including a share registry update. No major financial news.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on October 4, 2024, to incorporate by reference into several of its existing SEC registration statements. The filing includes an exhibit regarding a change of share registry.
Why It Matters
This filing is primarily administrative, updating registration statements and noting a change in share registry, which could impact how shareholders interact with the company's stock.
Risk Assessment
Risk Level: low — The filing is administrative and does not contain new financial information or significant operational updates.
Key Players & Entities
- ALTERITY THERAPEUTICS LTD (company) — Registrant
- PRANA BIOTECHNOLOGY LTD (company) — Former company name
- 0001213900-24-085193 (filing_id) — Accession Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being incorporated by reference into Alterity Therapeutics Ltd.'s existing Registration Statements on Form S-8 and Form F-3.
What specific exhibit is included with this filing?
The filing includes Exhibit 99.1, titled 'Change of Share Registry'.
When was Alterity Therapeutics Limited formerly known as?
Alterity Therapeutics Limited was formerly known as PRANA BIOTECHNOLOGY LTD, with a date of name change on January 5, 2001.
Which SEC Acts and Forms are referenced in relation to this filing?
This filing is pursuant to the Securities Exchange Act of 1934 and is incorporated into Registration Statements on Form S-8 and Form F-3.
What is the principal executive office address for Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Filing Stats: 188 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2024-10-04 06:26:24
Filing Documents
- ea0216771-6k_alterity.htm (6-K) — 14KB
- ea021677101ex99-1_alterity.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-24-085193.txt ( ) — 31KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Change of Share Registry 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: October 4, 2024 2